Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Staphylococcus Haemolyticus in the Neonatal Intensive Care Unit of CHSD in 2023: Analysis and Trends

NCT07013864 is registered in ClinicalTrials.gov with Centre Hospitalier de Saint-Denis as lead sponsor.

NCT NCT07013864
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07013864 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Staphylococcus Haemolyticus in the Neonatal Intensive Care Unit of CHSD in 2023: Analysis and Trends
Lead sponsor
Centre Hospitalier de Saint-Denis
Phase
Observational
Overall status
Completed
Start date
July 1, 2024
Completion date
September 30, 2024
Enrollment
28 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

catheter-related infections, cross infection, drug resistance, bacterial, infant, newborn, intensive care units, neonatal, sepsis, staphylococcal infections, staphylococcus haemolyticus